What is it?

Genexi accelerates the transition of cutting-edge biotech projects from research to the market. GEN token is qualified as a utility token. The token will be used as a medium of exchange within the ecosystem.

ICO Countries Not Allowed

The following countries are not allowed to participate in the crowdsale:

  • USA

Official Explainer Video

GENEXI Details

Blockchain Ethereum (ERC20)
Team Location Switzerland

Pre-ICO Details

Status | Pre-Sale Ended
Pre-ICO Start Date May 15
Pre-ICO End Date May 31
Pre-ICO Conversion

1 GEN = 0.01 USD

Pre-ICO Bonus

20%

ICO Details

Status | Ends in 10 days
KYC Required
ICO Start Date Jun 1
ICO End Date Jul 31
Soft Cap 20,000,000 USD
Hard Cap 70,000,000 USD
Total Supply 12,000,000,000 GEN
Investor Supply 8.400,000,000 GEN
ICO Conversion

1 GEN = 0.01 USD

Bonus Structure

17% Round 1 01.06 – 14.06
9% Round 2 15.06 – 28.06
5% Round 3 29.06 – 12.07
2% Round 4 13.07 – 31.07

Supply Distribution

70% Public Distribution
10% Long-term Foundation Budget
15% Founders, Team
5% Advisors and Early Contributors
----------
*Unsold tokens will be burned.

GENEXI Founding Team

 Alexey Zhelyaskov
Alexey Zhelyaskov

Co-Founder, CEO

Aleksei Kirillov
Aleksei Kirillov

Co-Founder, COO

Roman Gilvanov
Roman Gilvanov

Managing Director

Sergey Tiurin
Sergey Tiurin

Head of Medical Research

Andrew Zharkov
Andrew Zharkov

Head of Finance

Alexey Nosikov
Alexey Nosikov

Head of Operations

Andrew Marcus
Andrew Marcus

Head of Strategy

Bogdan Stepanov
Bogdan Stepanov

Head of Business Development

Anton Sklovets
Anton Sklovets

Head of Research

Daria Goriychuk
Daria Goriychuk

Head of HR